Skip to main navigation Skip to search Skip to main content

An Open Label Multicenter Extension Study to Determine Long Term Safety and Efficacy of Pregabalin (Lyrica) as Monotherapy in Patients with Partial Seizures

Grants and Contracts Details

StatusFinished
Effective start/end date8/1/081/31/14

Funding

  • Pfizer Inc.: $22,354.00